table of content
1 Introduction to Research & Analysis Reports
1.1 Large Molecule Drugs CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Large Molecule Drugs CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Large Molecule Drugs CDMO Overall Market Size
2.1 Global Large Molecule Drugs CDMO Market Size: 2023 VS 2030
2.2 Global Large Molecule Drugs CDMO Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Large Molecule Drugs CDMO Players in Global Market
3.2 Top Global Large Molecule Drugs CDMO Companies Ranked by Revenue
3.3 Global Large Molecule Drugs CDMO Revenue by Companies
3.4 Top 3 and Top 5 Large Molecule Drugs CDMO Companies in Global Market, by Revenue in 2023
3.5 Global Companies Large Molecule Drugs CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Large Molecule Drugs CDMO Players in Global Market
3.6.1 List of Global Tier 1 Large Molecule Drugs CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Large Molecule Drugs CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Large Molecule Drugs CDMO Market Size Markets, 2023 & 2030
4.1.2 Cell Line Development
4.1.3 Large Molecule Drug Substance Development
4.2 By Type - Global Large Molecule Drugs CDMO Revenue & Forecasts
4.2.1 By Type - Global Large Molecule Drugs CDMO Revenue, 2019-2024
4.2.2 By Type - Global Large Molecule Drugs CDMO Revenue, 2025-2030
4.2.3 By Type - Global Large Molecule Drugs CDMO Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Large Molecule Drugs CDMO Market Size, 2023 & 2030
5.1.2 Biological Technology
5.1.3 Clinical
5.1.4 Pharmaceutical
5.1.5 Others
5.2 By Application - Global Large Molecule Drugs CDMO Revenue & Forecasts
5.2.1 By Application - Global Large Molecule Drugs CDMO Revenue, 2019-2024
5.2.2 By Application - Global Large Molecule Drugs CDMO Revenue, 2025-2030
5.2.3 By Application - Global Large Molecule Drugs CDMO Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Large Molecule Drugs CDMO Market Size, 2023 & 2030
6.2 By Region - Global Large Molecule Drugs CDMO Revenue & Forecasts
6.2.1 By Region - Global Large Molecule Drugs CDMO Revenue, 2019-2024
6.2.2 By Region - Global Large Molecule Drugs CDMO Revenue, 2025-2030
6.2.3 By Region - Global Large Molecule Drugs CDMO Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Large Molecule Drugs CDMO Revenue, 2019-2030
6.3.2 US Large Molecule Drugs CDMO Market Size, 2019-2030
6.3.3 Canada Large Molecule Drugs CDMO Market Size, 2019-2030
6.3.4 Mexico Large Molecule Drugs CDMO Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Large Molecule Drugs CDMO Revenue, 2019-2030
6.4.2 Germany Large Molecule Drugs CDMO Market Size, 2019-2030
6.4.3 France Large Molecule Drugs CDMO Market Size, 2019-2030
6.4.4 U.K. Large Molecule Drugs CDMO Market Size, 2019-2030
6.4.5 Italy Large Molecule Drugs CDMO Market Size, 2019-2030
6.4.6 Russia Large Molecule Drugs CDMO Market Size, 2019-2030
6.4.7 Nordic Countries Large Molecule Drugs CDMO Market Size, 2019-2030
6.4.8 Benelux Large Molecule Drugs CDMO Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Large Molecule Drugs CDMO Revenue, 2019-2030
6.5.2 China Large Molecule Drugs CDMO Market Size, 2019-2030
6.5.3 Japan Large Molecule Drugs CDMO Market Size, 2019-2030
6.5.4 South Korea Large Molecule Drugs CDMO Market Size, 2019-2030
6.5.5 Southeast Asia Large Molecule Drugs CDMO Market Size, 2019-2030
6.5.6 India Large Molecule Drugs CDMO Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Large Molecule Drugs CDMO Revenue, 2019-2030
6.6.2 Brazil Large Molecule Drugs CDMO Market Size, 2019-2030
6.6.3 Argentina Large Molecule Drugs CDMO Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Large Molecule Drugs CDMO Revenue, 2019-2030
6.7.2 Turkey Large Molecule Drugs CDMO Market Size, 2019-2030
6.7.3 Israel Large Molecule Drugs CDMO Market Size, 2019-2030
6.7.4 Saudi Arabia Large Molecule Drugs CDMO Market Size, 2019-2030
6.7.5 UAE Large Molecule Drugs CDMO Market Size, 2019-2030
7 Large Molecule Drugs CDMO Companies Profiles
7.1 Patheon
7.1.1 Patheon Company Summary
7.1.2 Patheon Business Overview
7.1.3 Patheon Large Molecule Drugs CDMO Major Product Offerings
7.1.4 Patheon Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.1.5 Patheon Key News & Latest Developments
7.2 Eurofins Scientific
7.2.1 Eurofins Scientific Company Summary
7.2.2 Eurofins Scientific Business Overview
7.2.3 Eurofins Scientific Large Molecule Drugs CDMO Major Product Offerings
7.2.4 Eurofins Scientific Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.2.5 Eurofins Scientific Key News & Latest Developments
7.3 Samsung Biologics
7.3.1 Samsung Biologics Company Summary
7.3.2 Samsung Biologics Business Overview
7.3.3 Samsung Biologics Large Molecule Drugs CDMO Major Product Offerings
7.3.4 Samsung Biologics Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.3.5 Samsung Biologics Key News & Latest Developments
7.4 Catalent, Inc.
7.4.1 Catalent, Inc. Company Summary
7.4.2 Catalent, Inc. Business Overview
7.4.3 Catalent, Inc. Large Molecule Drugs CDMO Major Product Offerings
7.4.4 Catalent, Inc. Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.4.5 Catalent, Inc. Key News & Latest Developments
7.5 Rentschler Biopharma SE
7.5.1 Rentschler Biopharma SE Company Summary
7.5.2 Rentschler Biopharma SE Business Overview
7.5.3 Rentschler Biopharma SE Large Molecule Drugs CDMO Major Product Offerings
7.5.4 Rentschler Biopharma SE Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.5.5 Rentschler Biopharma SE Key News & Latest Developments
7.6 AGC Biologics
7.6.1 AGC Biologics Company Summary
7.6.2 AGC Biologics Business Overview
7.6.3 AGC Biologics Large Molecule Drugs CDMO Major Product Offerings
7.6.4 AGC Biologics Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.6.5 AGC Biologics Key News & Latest Developments
7.7 Recipharm AB
7.7.1 Recipharm AB Company Summary
7.7.2 Recipharm AB Business Overview
7.7.3 Recipharm AB Large Molecule Drugs CDMO Major Product Offerings
7.7.4 Recipharm AB Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.7.5 Recipharm AB Key News & Latest Developments
7.8 Siegfried Holding AG
7.8.1 Siegfried Holding AG Company Summary
7.8.2 Siegfried Holding AG Business Overview
7.8.3 Siegfried Holding AG Large Molecule Drugs CDMO Major Product Offerings
7.8.4 Siegfried Holding AG Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.8.5 Siegfried Holding AG Key News & Latest Developments
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.9.3 FUJIFILM Diosynth Biotechnologies Large Molecule Drugs CDMO Major Product Offerings
7.9.4 FUJIFILM Diosynth Biotechnologies Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.9.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.10 Scorpius
7.10.1 Scorpius Company Summary
7.10.2 Scorpius Business Overview
7.10.3 Scorpius Large Molecule Drugs CDMO Major Product Offerings
7.10.4 Scorpius Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.10.5 Scorpius Key News & Latest Developments
7.11 Ardena
7.11.1 Ardena Company Summary
7.11.2 Ardena Business Overview
7.11.3 Ardena Large Molecule Drugs CDMO Major Product Offerings
7.11.4 Ardena Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.11.5 Ardena Key News & Latest Developments
7.12 Alcami
7.12.1 Alcami Company Summary
7.12.2 Alcami Business Overview
7.12.3 Alcami Large Molecule Drugs CDMO Major Product Offerings
7.12.4 Alcami Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.12.5 Alcami Key News & Latest Developments
7.13 Cytiva
7.13.1 Cytiva Company Summary
7.13.2 Cytiva Business Overview
7.13.3 Cytiva Large Molecule Drugs CDMO Major Product Offerings
7.13.4 Cytiva Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.13.5 Cytiva Key News & Latest Developments
7.14 Thermo Fisher Scientific
7.14.1 Thermo Fisher Scientific Company Summary
7.14.2 Thermo Fisher Scientific Business Overview
7.14.3 Thermo Fisher Scientific Large Molecule Drugs CDMO Major Product Offerings
7.14.4 Thermo Fisher Scientific Large Molecule Drugs CDMO Revenue in Global Market (2019-2024)
7.14.5 Thermo Fisher Scientific Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
